Sign inGet started

Huhn Stephen L.

Insider CIK 1863904 · CTNM CMO & Sr VP, Clinical Dev.

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CTNM Contineum Therapeutics, In A Award deriv2025-01-312025-01-31110,000— $0110,000SEC↗
CTNM Contineum Therapeutics, In M Exercise deriv2024-08-132024-08-1412,800— $0161,394SEC↗
CTNM Contineum Therapeutics, In M Exercise2024-08-132024-08-1412,800$1.01 $12.9K12,800SEC↗
CTNM Contineum Therapeutics, In A Award deriv2024-05-242024-05-29100,000— $0100,000SEC↗